Cui, H., & Elkord, E. Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach? MDPI AG.
Chicago Style (17th ed.) CitationCui, Haozhe, and Eyad Elkord. Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach? MDPI AG.
MLA (9th ed.) CitationCui, Haozhe, and Eyad Elkord. Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach? MDPI AG.
Warning: These citations may not always be 100% accurate.